Applied Genetic Technologies (AGTC) Posts Q4 Loss of 48c/Share

Applied Genetic Technologies (NASDAQ: AGTC) reported Q4 EPS of ($0.48), $0.07 worse than the analyst estimate of ($0.41). Revenue for the quarter came in at $713 thousand versus the consensus estimate of $630 thousand.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c